Dance Study for Post-surgical Pain in Breast Cancer Survivors
Launched by DANA-FARBER CANCER INSTITUTE · Dec 26, 2024
Trial Information
Current as of November 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Dance Study is a clinical trial designed to explore how a 12-week virtual dance program can help improve pain and quality of life for women who have experienced persistent post-surgical pain after breast cancer surgery, such as a mastectomy or lumpectomy. The study aims to see if this enjoyable and gentle form of exercise can make a difference for those living with ongoing pain following their treatment.
To participate in this study, women aged 18 and older who have a history of early-stage invasive breast cancer may be eligible if they have been experiencing moderate to severe pain for at least three months after surgery. Participants will need to be able to read and understand English and perform seated exercises. This study is not yet recruiting, but it offers a unique opportunity for those struggling with pain to potentially find relief through movement and dance. If you or someone you know is interested, it’s a great chance to engage in a supportive program while contributing to important research.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • History of Stage 0-III invasive breast cancer
- • Having undergone lumpectomy or mastectomy
- • Moderate to severe persistent post-surgical pain, as defined by pain scores ≥3 on a numerical rating scale (NRS) of 0-10 (10 being the most severe pain) at least 3 months after completion of surgery, chemotherapy, and/or radiation
- • Pain scores of 3-4 are categorized as moderate pain; scores of 5-10 are categorized as severe pain26
- • Age ≥ 18 years
- • Able to read and understand English (to complete required questionnaires and participate in classes)
- • Ability to provide informed consent
- • Ability to perform seated exercises
- Exclusion Criteria:
- • Unstable cardiovascular disease in the last 6 months
- • Psychiatric disorders or conditions that would preclude participation in the study intervention (e.g. untreated major depression or psychosis, untreated substance use disorder, severe personality disorder)
- • Metastatic breast or other concurrent cancer
- • Pregnant
- • Recent history of attending regular dance or similar classes (e.g. yoga or tai chi classes i.e. 20 or more classes in the past 6 months)
- • Planned surgery anticipated during the intervention period
- • History of a chronic medical condition that has the potential to significantly impact upper extremity function (e.g. stroke, Parkinson's disease, Multiple Sclerosis)
- • Currently enrolled in a physical therapy course
- • Presence of medical conditions or medications that would prohibit participation in an exercise program
About Dana Farber Cancer Institute
The Dana-Farber Cancer Institute is a premier cancer research and treatment institution located in Boston, Massachusetts. Renowned for its commitment to advancing cancer care through innovative research, the institute integrates cutting-edge clinical trials with a multidisciplinary approach to patient care. With a focus on translating scientific discoveries into effective therapies, Dana-Farber collaborates with a network of leading researchers and healthcare professionals to improve outcomes for patients with cancer. The institute’s dedication to education, advocacy, and community engagement further underscores its mission to eradicate cancer and enhance the quality of life for those affected by the disease.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Jennifer Ligibel, MD
Principal Investigator
Dana-Farber Cancer Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported